Phase II trial PD-L1/PD-1 blockade Avelumab (MSB0010718C) with Chemoradiotherapy for Locally Advanced Resectable Rectal Cancer

  • Shapiro, Jeremy (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Short titleAveRec Trial
StatusFinished
Effective start/end date5/12/19 → 31/12/22

Keywords

  • Medical Oncology
  • Rectal Cancer
  • Clinical trial

Clinical Trial Phase

  • Phase II